Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00391300
Status:
UNKNOWN
Last Update Posted:
2013-12-18
First Post:
2006-10-02
Brief Title:
Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions
Sponsor:
Eastern Virginia Medical School
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
Development of an Electrical Diagnostic for Melanoma and Other Cutaneous Malignancies
Status:
UNKNOWN
Status Verified Date:
2008-10
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE New diagnostic procedures such as bioelectric field imaging may help find and diagnose melanoma and other skin cancers It may also be a less invasive way to check for skin cancer
PURPOSE This phase I trial is studying bioelectric field imaging in diagnosing melanoma and other skin cancers in patients with skin lesions
PURPOSE This phase I trial is studying bioelectric field imaging in diagnosing melanoma and other skin cancers in patients with skin lesions
Detailed Description:
OBJECTIVES
To determine if the hand-held Bioelectric Field Imager can be used to measure the electric field in skin of various body surfaces including face neck shoulders arms hands chest back legs and feet during the course of examination and treatment of patients with suspected malignant skin lesions
To determine if there is a significant difference between the lateral electric field strength near benign and malignant skin lesions in the same individual
OUTLINE Patients undergo scanning of their skin lesions and nearby healthy skin using the Bioelectric Field Imager BFI The lesions are then biopsied for histological diagnosis Histological data from the biopsy is correlated with the electric field data from the BFI
To determine if the hand-held Bioelectric Field Imager can be used to measure the electric field in skin of various body surfaces including face neck shoulders arms hands chest back legs and feet during the course of examination and treatment of patients with suspected malignant skin lesions
To determine if there is a significant difference between the lateral electric field strength near benign and malignant skin lesions in the same individual
OUTLINE Patients undergo scanning of their skin lesions and nearby healthy skin using the Bioelectric Field Imager BFI The lesions are then biopsied for histological diagnosis Histological data from the biopsy is correlated with the electric field data from the BFI
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EVMS-BFI and Lesions | None | None | None |